Literature DB >> 29329020

A novel mouse model of atopic dermatitis that is T helper 2 (Th2)-polarized by an epicutaneous allergen.

Hyun Jung Park1, Wahn Soo Choi2, Won Young Lee3, Youngsok Choi4, Chankyu Park1, Jin Hoi Kim1, Kwon Ho Hong1, Hyuk Song5.   

Abstract

The pathogenesis of atopic dermatitis (AD) involves T helper 2 (Th2) cells, and effective therapies remain elusive due to the paucity of animal models. We aimed to develop a mouse model of an immune system aberration caused by allergen. Experiments were conducted in two phases. In experiment 1, BALB/c mice were sensitized with one of four chemical allergens - toluene diisocyanate (TDI), hexamethylene diisocyanate (HDI), trimellitic anhydride (TMA), or 2,4-dinitrochlorobenzene (DNCB) - for 3 weeks. Based on results of experiment 1, immunological features were compared between TMA-sensitized BALB/c mice and NC/Nga mice, after exposure to mite extracts, harmful chemicals and detergents in experiment 2. Sensitization by allergen caused a large number of pathological changes in the skin, and an increase in mast cell number. TMA-sensitized BALB/c mice models showed higher sensitivity to an environmental allergen than NC/Nga mice did. Overall, the initial sensitization with TMA leads to disturbances in Th2-mediated immunity.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 29329020     DOI: 10.1016/j.etap.2017.12.025

Source DB:  PubMed          Journal:  Environ Toxicol Pharmacol        ISSN: 1382-6689            Impact factor:   4.860


  3 in total

1.  Phloretin alleviates dinitrochlorobenzene-induced dermatitis in BALB/c mice.

Authors:  Chieh-Shan Wu; Shih-Chao Lin; Shiming Li; Yu-Chih Chiang; Nicole Bracci; Caitlin W Lehman; Kuo-Tung Tang; Chi-Chien Lin
Journal:  Int J Immunopathol Pharmacol       Date:  2020 Jan-Dec       Impact factor: 3.219

2.  The prevention of 2,4-dinitrochlorobenzene-induced inflammation in atopic dermatitis-like skin lesions in BALB/c mice by Jawoongo.

Authors:  Jin Mo Ku; Se Hyang Hong; Soon Re Kim; Han-Seok Choi; Hyo In Kim; Dong Uk Kim; So Mi Oh; Hye Sook Seo; Tai Young Kim; Yong Cheol Shin; Chunhoo Cheon; Seong-Gyu Ko
Journal:  BMC Complement Altern Med       Date:  2018-07-13       Impact factor: 3.659

3.  Comprehensive Analysis of the Safety Profile of a Single-Stranded RNA Nano-Structure Adjuvant.

Authors:  Hyeong-Jun Park; Hae Li Ko; Dong-Hoon Won; Da-Bin Hwang; Yoo-Sub Shin; Hye-Won Kwak; Hye-Jung Kim; Jun-Won Yun; Jae-Hwan Nam
Journal:  Pharmaceutics       Date:  2019-09-07       Impact factor: 6.321

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.